On June 24, 2022, the Supreme Court of the United States issued a 5-4 ruling in Dobbs v. Jackson Women's Health Organization, holding that…
September 2022, Paper: "The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare…
/centers/mrcbg/programs/growthpolicy/establishing-academic-homes-homelessness-call-action-howard-koh
September 5, 2022, Paper: "Although homelessness ranks as one of society’s most pressing and visible health equity challenges, the academic…
One of our great urbanists and one of our great public health experts join forces to reckon with how cities are changing in the face of…
September 6, 2022, Interview: "Policymakers of every leaning have vowed to rein in prescription drug costs, with little success. But…
September 2022, Audio: "On our 100th episode, Leemore Dafny from Harvard Business School joins Health Affairs Editor-in-Chief Alan Weil to…
The COVID-19 pandemic (and its aftermath) highlights a critical need to communicate health information effectively to the global public.…
In 2020 Medicare reintroduced Alzheimer’s disease and related dementias (ADRD) Hierarchical Condition Categories (HCCs) to risk-adjust…
/centers/mrcbg/programs/growthpolicy/medicare-enters-pharmaceutical-purchasing-business-david-cutler
September 1, 2022, Paper: "The recently passed Inflation Reduction Act made fundamental changes to federal health and climate policy. The…
Past pandemic experience can affect health outcomes in future pandemics. This paper focuses on the last major influenza pandemic in 1968 (…